Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinson Disease (PD)”

1,134 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,134 results

Early research (Phase 1)Study completedNCT03562494
What this trial is testing

VY-AADC02 for Parkinson's Disease With Motor Fluctuations (RESTORE-1)

Who this might be right for
Parkinson's Disease
Neurocrine Biosciences 14
Testing effectiveness (Phase 2)Ended earlyNCT03306329
What this trial is testing

DNS-7801 vs. Placebo in Parkinson's Disease

Who this might be right for
Parkinson's Disease
Dart NeuroScience, LLC 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT04491383
What this trial is testing

Tocotrienols in Parkinson's Disease (PD)

Who this might be right for
Neuro-Degenerative DiseaseParkinson Disease
National Neuroscience Institute 100
Large-scale testing (Phase 3)Study completedNCT02494583
What this trial is testing

Study of Pembrolizumab (MK-3475) as First-Line Monotherapy and Combination Therapy for Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-062/KEYNOTE-062)

Who this might be right for
Gastric Adenocarcinoma
Merck Sharp & Dohme LLC 763
Not applicableLooking for participantsNCT04179695
What this trial is testing

Evaluation of a New Communication Aid Tool to Favor Global Patient Centered Care

Who this might be right for
Parkinson's Disease
University Hospital, Lille 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07414290
What this trial is testing

A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R08b in Parkinson's Disease Patients With GBA1 Mutations

Who this might be right for
Parkinson Disease (PD)
Shanghai Vitalgen BioPharma Co., Ltd. 17
Early research (Phase 1)Study completedNCT02071810
What this trial is testing

Tolerability, Pharmacokinetics and Pharmacodynamics of BIA 9-1067

Who this might be right for
Parkinson's Disease (PD)
Bial - Portela C S.A. 34
Testing effectiveness (Phase 2)WithdrawnNCT00758368
What this trial is testing

Comparison of Continuous and Pulsatile Apomorphine in Parkinson's Disease

Who this might be right for
Parkinson's Disease
Oregon Health and Science University
Early research (Phase 1)Study completedNCT05017012
What this trial is testing

Evaluate the Bioavailability of Pembrolizumab (MK-3475) Via Subcutaneous (SC) Injection of Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180) [MK-3475A] In Advanced Solid Tumors (MK-3475A-C18)

Who this might be right for
Advanced or Metastatic Solid Tumors
Merck Sharp & Dohme LLC 142
Not applicableUnknownNCT01223781
What this trial is testing

Biofeedback-based Motor Learning to Ameliorate Freezing of Gait

Who this might be right for
GaitParkinson Disease
Tel-Aviv Sourasky Medical Center 40
Not applicableUnknownNCT06543563
What this trial is testing

Esketamine in Microelectrode Recording-guided Subthalamic Deep-Brain Stimulation for Parkinson's Disease

Who this might be right for
PD - Parkinson's DiseaseDeep Brain StimulationEsketamine
Beijing Tiantan Hospital 102
Not applicableLooking for participantsNCT03523065
What this trial is testing

Chinese PD-GBA Registry

Who this might be right for
Parkinson Disease
Xiangya Hospital of Central South University 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT06483334
What this trial is testing

Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Plus Enfortumab Vedotin (EV) With and Without Pembrolizumab in Advanced Urothelial Carcinoma (MK-3475-04C/KEYMAKER-U04)

Who this might be right for
Metastatic Urothelial CarcinomaLocally Advanced Urothelial Carcinoma
Merck Sharp & Dohme LLC 38
Large-scale testing (Phase 3)Study completedNCT02256436
What this trial is testing

Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)

Who this might be right for
Urothelial Cancer
Merck Sharp & Dohme LLC 542
Not applicableUnknownNCT00790634
What this trial is testing

Mechanisms of Fronto-Subcortical Dysfunction: Comparing PD and OCD

Who this might be right for
Parkinson's DiseaseObsessive-Compulsive Disorder
Sheba Medical Center 100
Not applicableUnknownNCT04147377
What this trial is testing

Effects of Behavioral Interventions Based on Sensory Cues on FOG in PD After STN-DBS

Who this might be right for
Parkinson Disease
Seoul National University Hospital 60
Testing effectiveness (Phase 2)Study completedNCT03516981
What this trial is testing

Biomarker-Directed, Pembrolizumab (MK-3475) Based Combination Therapy for Advanced Non-Small Cell Lung Cancer (MK-3475-495/KEYNOTE-495)

Who this might be right for
Advanced Non-Small Cell Lung Cancer
Merck Sharp & Dohme LLC 245
Not applicableLooking for participantsNCT06993571
What this trial is testing

Cerebellar Transcranial Alternating Current Stimulation (tACS) to Modulate Parkinson's Disease Tremor

Who this might be right for
Parkinson's Disease (PD)Tremor
Universitätsklinikum Hamburg-Eppendorf 10
Early research (Phase 1)Study completedNCT01725802
What this trial is testing

A Safety, Tolerability, and Plasma Concentration Study of Levodopa/Carbidopa Subcutaneous Solution (ND0612) in Parkinson's Disease (PD) Patients

Who this might be right for
Parkinson's Disease
NeuroDerm Ltd. 8
Not applicableUnknownNCT06367101
What this trial is testing

AR Stimulation Effects on Gait, Anxiety, and Brain Connectivity in Parkinson's Disease

Who this might be right for
Parkinson Disease(PD)
Chang Gung University 90
Next Page